Sally Atef Fahim (Sally A Fahim)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Topics

Breast Cancer Cells

Ischemia Reperfusion Injury

Top Venues

Scientific reports

Bioscience reports

Human & experimental toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Aliaa I Gaballah, Aliaa A Elsherbiny, Marwa Sharaky, Najat O Hamed, Nahed A Raslan, Abdullah Almilaibary, Reda Mohamed Abdrabbou Fayyad, Mona S Ousman, Ahmed M E Hamdan, Sally Atef Fahim
Dexamethasone-tamoxifen combination exerts synergistic therapeutic effects in tamoxifen-resistance breast cancer cells. Bioscience reports 44 (7) (2024)
Sally Atef Fahim, Yehia A ElZohairy, Rehab I Moustafa
Favipiravir, an antiviral drug, in combination with tamoxifen exerts synergistic effect in tamoxifen-resistant breast cancer cells via hTERT inhibition. Scientific reports 14 (1) (2024)
Sally Atef Fahim, Yehia A ElZohairy, Rehab I Moustafa
Favipiravir, an antiviral drug, in combination with tamoxifen exerts synergistic effect in tamoxifen-resistant breast cancer cells via hTERT inhibition. Scientific reports 14 (1) (2024)
Aliaa I Gaballah, Aliaa A Elsherbiny, Marwa Sharaky, Najat O Hamed, Nahed A Raslan, Abdullah Almilaibary, Reda Mohamed Abdrabbou Fayyad, Mona S Ousman, Ahmed M E Hamdan, Sally Atef Fahim
Dexamethasone-tamoxifen combination exerts synergistic therapeutic effects in tamoxifen-resistance breast cancer cells. Bioscience reports 44 (7) (2024)
Aliaa I Gaballah, Aliaa A Elsherbiny, Marwa Sharaky, Najat O Hamed, Nahed A Raslan, Abdullah Almilaibary, Reda Mohamed Abdrabbou Fayyad, Mona S Ousman, Ahmed M E Hamdan, Sally Atef Fahim
Dexamethasone-tamoxifen combination exerts synergistic therapeutic effects in tamoxifen-resistance breast cancer cells. Bioscience reports 44 (7) (2024)
Sally Atef Fahim, Yehia A ElZohairy, Rehab I Moustafa
Favipiravir, an antiviral drug, in combination with tamoxifen exerts synergistic effect in tamoxifen-resistant breast cancer cells via hTERT inhibition. Scientific reports 14 (1) (2024)
Sally Atef Fahim, Yehia A ElZohairy, Rehab I Moustafa
Favipiravir, an antiviral drug, in combination with tamoxifen exerts synergistic effect in tamoxifen-resistant breast cancer cells via hTERT inhibition. Scientific reports 14 (1) (2024)
Sally Atef Fahim, Samar Ibrahim, Samer A Tadros, Osama A Badary
Protective effects of butylated hydroxytoluene on the initiation of N-nitrosodiethylamine-induced hepatocellular carcinoma in albino rats. Human & experimental toxicology 42 (2023)
Tarek Mohamed Kamal Motawi, Nermin Abdel Hamid Sadik, Dina Sabry, Nancy Nabil Shahin, Sally Atef Fahim
rs2267531, a promoter SNP within glypican-3 gene in the X chromosome, is associated with hepatocellular carcinoma in Egyptians. Scientific reports 9 (1) (2019)